The pathological potential of LRP/LR in cancer has been targeted using numerous anti-LRP/LR tools including anti-LRP/LR specific antibodies in order to impede cancer propagating processes including, increased invasion[3], cellular proliferation[44], metastasis[29, 33] and evasion of apoptosis[36]. Here, RPSA is linked to cancer.